Neuro-Oncology Reviews
Volume
25 Number 2
31 January 2023
Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 2, 31 January
Scherm A,
Ippen FM, Hau P, Baurecht H, Wick W, Gempt J, Knüttel H,
Leitzmann MF, Seliger C.
Targeted
therapies in patients with newly diagnosed glioblastoma-A
systematic meta-analysis of randomized clinical trials.
Int
J Cancer. 2023 Jan 16∟.
doi: 10.1002/ijc.34433∟.
PMID: 36647335∟.
Review, Meta-analysis. ˍ
Vallero SG,
Bertero L, Morana G, Sciortino P, Bertin D, Mussano A, Ricci FS,
Peretta P, Fagioli F.
Pediatric
diffuse midline glioma H3K27- altered: A complex clinical and
biological landscape behind a neatly defined tumor type.
Front
Oncol. 2023 Jan 16, 2022;12:1082062∟.
doi: 10.3389/fonc.2022.1082062∟.
PMID: 36727064∟.
Review. ˍ
Arrieta VA,
Dmello C, McGrail DJ, Brat DJ, Lee-Chang C, Heimberger AB, Chand
D, Stupp R, Sonabend AM.
Immune
checkpoint blockade in glioblastoma: from tumor heterogeneity to
personalized treatment.
J
Clin Invest. 2023 Jan 17;133(2):e163447∟.
doi: 10.1172/JCI163447∟.
PMID: 36647828∟.
Review. ˍ
Gonzalez Castro LN,
Arrillaga-Romany IC, Batchelor TT.
Challenges
and Opportunities for Clinical Trials in Patients With
Glioma.
JAMA
Neurol. 2023 Jan 17∟.
doi: 10.1001/jamaneurol.2022.4924∟.
PMID: 36648934∟.
Viewpoint˰ ˍ
Johanssen T,
McVeigh L, Erridge S, Higgins G, Straehla J, Frame M, Aittokallio
T, Carragher NO, Ebner D.
Glioblastoma
and the search for non-hypothesis driven combination therapeutics
in academia.
Front
Oncol. 2023 Jan 17, 2022;12:1075559∟.
doi: 10.3389/fonc.2022.1075559∟.
PMID: 36733367∟.
Review. ˍ
Najafi M,
Jahanbakhshi A, Finocchi Ghersi S, Giaccherini L, Botti A,
Cavallieri F, Rossi J, Iori F, Iotti C, Ciammella P, Nabiuni M,
Gomar M, Rezaie O, Cozzi S.
Clinical
Effects of Immuno-Oncology Therapy on Glioblastoma Patients: A
Systematic Review.
Brain
Sci. 2023 Jan 17;13(2):159∟.
doi: 10.3390/brainsci13020159∟.
PMID: 36831702∟.
Review. ˍ
Thirugnanasambandam
RP, Silva GMV, Wu AH, Kim CJ, Cimpeanu E, Minkowitz J, Shao CY,
Chiu E.
Cystic
Glioblastoma: A Mimicker of Infection? A Case Report and
Literature Review.
Case
Rep Oncol Med. 2023 Jan 17;2023:7348188∟.
doi: 10.1155/2023/7348188∟.
PMID: 36704640∟.
Case report, Review. ˍ
Soni N, Ora
M, Jena A, Rana P, Mangla R, Ellika S, Almast J, Puri S, Meyers
SP.
Amino
Acid Tracer PET MRI in Glioma Management: What a Neuroradiologist
Needs to Know.
AJNR
Am J Neuroradiol. 2023 Jan 19∟.
doi: 10.3174/ajnr.A7762∟.
PMID: 36657945∟.
Review.
ˍ
Chen Y, Zhao
C, Li S, Wang J, Zhang H.
Immune
Microenvironment and Immunotherapies for Diffuse Intrinsic Pontine
Glioma.
Cancers
(Basel). 2023 Jan 18;15(3):602∟.
doi: 10.3390/cancers15030602∟.
PMID: 36765560∟.
Review. ˍ
Kalluri AL,
Shah PP, Lim M.
The
Tumor Immune Microenvironment in Primary CNS Neoplasms: A Review
of Current Knowledge and Therapeutic Approaches.
Int
J Mol Sci. 2023 Jan 19;24(3):2020∟.
doi: 10.3390/ijms24032020∟.
PMID: 36768342∟.
Review. ˍ
*
Kao YS, Yeh
CC, Chen YF.
The
Relationship between Cancer and Dementia: An Updated
Review.
Cancers
(Basel). 2023 Jan 19;15(3):640∟.
doi: 10.3390/cancers15030640∟.
PMID: 36765598∟.
Review. ˍ
Romano A,
Palizzi S, Romano A, Moltoni G, Di Napoli A, Maccioni F, Bozzao
A.
Diffusion
Weighted Imaging in Neuro-Oncology: Diagnosis, Post-Treatment
Changes, and Advanced Sequences-An Updated Review.
Cancers
(Basel). 2023 Jan 19;15(3):618∟.
doi: 10.3390/cancers15030618∟.
PMID: 36765575∟.
Review. ˍ
Vymazal J,
Kazda T, Novak T, Slanina P, Sroubek J, Klener J, Hrbac T, Syrucek
M, Rulseh AM.
Eighteen
years' experience with tumor treating fields in the treatment of
newly diagnosed glioblastoma.
Front
Oncol. 2023 Jan 19;12:1014455∟.
doi: 10.3389/fonc.2022.1014455∟.
PMID: 36741707∟.
Observational study, Review. ˍ
Collée
E, Vincent A, Visch-Brink E, De Witte E, Dirven C, Satoer
D.
Localization
patterns of speech and language errors during awake brain surgery:
a systematic review.
Neurosurg
Rev. 2023 Jan 20;46(1):38∟.
doi: 10.1007/s10143-022-01943-9∟.
PMID: 36662312∟.
Review.
ˍ
McLaughlin A,
Lakshmanan R, Dyke J, Warne R, Saha S, Lind C, Bynevelt M.
Diffuse
paediatric cerebellar glioma: two identical imaging phenotypes of
an extremely rare entity with disparate pathology.
Childs
Nerv Syst. 2023 Jan 20∟.
doi: 10.1007/s00381-023-05836-0∟.
PMID: 36658366∟.
Case report, Review˰ ˍ
Morimoto T,
Nakazawa T, Maeoka R, Nakagawa I, Tsujimura T, Matsuda R.
Natural
Killer Cell-Based Immunotherapy against Glioblastoma.
Int
J Mol Sci. 2023 Jan 20;24(3):2111∟.
doi: 10.3390/ijms24032111∟.
PMID: 36768432∟.
Review. ˍ
Ritchey
AK et al, PDQ Pediatric Treatment Editorial Board.
Childhood
Brain Stem Glioma Treatment (PDQ®): Patient Version.
PDQ
Cancer Inf Summ. 2023
Jan
20∟.
Bookshelf ID:
NBK65856∟.
PMID: 26389295∟.
Review.
ˍ
Salari N,
Ghasemi H, Fatahian R, Mansouri K, Dokaneheifard S, Shiri MH,
Hemmati M, Mohammadi M.
The
global prevalence of primary central nervous system tumors: a
systematic review and meta-analysis.
Eur
J Med Res. 2023 Jan 20;28(1):39∟.
doi: 10.1186/s40001-023-01011-y∟.
PMID: 36670466∟.
Review, Meta-analysis. ˍ
Dighe OR,
Korde P, Bisen YT, Iratwar S, Kesharwani A, Vardhan S, Singh
A.
Emerging
Recombinant Oncolytic Poliovirus Therapies Against Malignant
Glioma: A Review.
Cureus.
2023 Jan 21;15(1):e34028∟.
doi: 10.7759/cureus.34028∟.
PMID: 36814733∟.
Review. ˍ
Anastasaki C,
Gao Y, Gutmann DH.
Neurons
as stromal drivers of nervous system cancer formation and
progression.
Dev
Cell. 2023 Jan 23;58(2):81-93∟.
doi: 10.1016/j.devcel.2022.12.011∟.
PMID: 36693322∟.
Review. ˍ
Vacher E,
Rodriguez Ruiz M, Rees JH.
Management
of brain tumour related epilepsy (BTRE): a narrative review and
therapy recommendations.
Br
J Neurosurg. 2023 Jan 24:1-8∟.
doi: 10.1080/02688697.2023.2170326∟.
PMID: 36694327∟.
Review˰ ˍ
Lindner
T, Bolar DS, Achten E, Barkhof F, Bastos-Leite AJ, Detre JA, Golay
X, Günther M, Wang DJJ, Haller S, Ingala S, Jäger HR,
Jahng GH, Juttukonda MR, Keil VC, Kimura H, Ho ML, Lequin M, Lou
X, Petr J, Pinter N, Pizzini FB, Smits M, Sokolska M, Zaharchuk G,
Mutsaerts HJMM; on behalf of the ISMRM Perfusion Study Group.
Current
state and guidance on arterial spin labeling perfusion MRI in
clinical neuroimaging.
Magn
Reson Med.
2023 Jan 25;89(5):2024-2047. doi:
10.1002/mrm.29572. PMID:
36695294. Review; Guidelines. ˍ
Pineda E, Domenech M, Hernández
A, Comas S, Balaña C.
Recurrent
Glioblastoma: Ongoing Clinical Challenges and Future
Prospects.
Onco
Targets Ther. 2023 Jan 25;16:71-86∟.
doi: 10.2147/OTT.S366371∟.
PMID: 36721854∟.
Review.
ˍ
Thrull M,
Atasi K, Boese LM, Cakar M, Heller U, Jansen N, Menzel LC, Omaimen
H, Theis K, Karacic D, Dimov D, Coras R, Klingebiel R.
Transdural
Skull Base Infiltration by Glioblastoma: Case Report and Review of
the Literature.
Case
Rep Otolaryngol. 2023 Jan 25;2023:4727288∟.
doi: 10.1155/2023/4727288∟.
PMID: 36742066∟.
Case report, Review. ˍ
Wang F, Dong
J, Zhang J, Zhao H, Wang N, Jin J, Yan X, Gao X, Liu H, Hu
S.
Rapid
progression of subcutaneous glioblastoma: A case report and
literature review.
Front
Oncol. 2023 Jan 25;13:935944∟.
doi: 10.3389/fonc.2023.935944∟.
PMID: 36761958∟.
Case report, Review. ˍ
Greuter L,
Hallenberger T, Guzman R, Soleman J.
Neurosurgical
Treatment and Outcome of Pediatric Skull Base Lesions: A Case
Series and Review of the Literature.
Children
(Basel). 2023 Jan 26;10(2):216∟.
doi: 10.3390/children10020216∟.
PMID: 36832345∟.
Case report, Review. ˍ
Jiang S, Chai
H, Tang Q.
Advances
in the intraoperative delineation of malignant glioma
margin.
Front
Oncol. 2023 Jan 26;13:1114450∟.
doi: 10.3389/fonc.2023.1114450∟.
PMID: 36776293∟.
Review. ˍ
*
Ma Y, Wang Y,
Nie C, Lin Y.
The
efficacy of targeted therapy combined with radiotherapy and
temozolomide-based chemotherapy in the treatment of glioma: A
systemic review and meta-analysis of phase II/III randomized
controlled trials.
Front
Oncol. 2023 Jan 26;13:1082539∟.
doi: 10.3389/fonc.2023.1082539∟.
PMID: 36776303∟.
Review, Meta-analysis. ˍ
Martucci M,
Russo R, Schimperna F, D'Apolito G, Panfili M, Grimaldi A, Perna
A, Ferranti AM, Varcasia G, Giordano C, Gaudino S.
Magnetic
Resonance Imaging of Primary Adult Brain Tumors: State of the Art
and Future Perspectives.
Biomedicines.
2023 Jan 26;11(2):364∟.
doi: 10.3390/biomedicines11020364∟.
PMID: 36830900∟.
Review. ˍ
Xie X, Bao S,
Zhao H, Li L, Fu X.
Efficacy
and safety of bevacizumab for treating glioblastoma: a systematic
review and meta-analysis of phase II and III randomized controlled
trials.
Cancer
Invest. 2023 Jan 27:1-15∟.
doi: 10.1080/07357907.2023.2174261∟.
PMID: 36705341∟.
Review, Meta-analysis˰ ˍ
Elias AF, Lin
BC, Piggott BJ.
Ion
Channels in Gliomas-From Molecular Basis to Treatment.
Int
J Mol Sci. 2023 Jan 28;24(3):2530∟.
doi: 10.3390/ijms24032530∟.
PMID: 36768856∟.
Review. ˍ
Zhang AB,
Mozaffari K, Aguirre B, Li V, Kubba R, Desai NC, Wei D, Yang I,
Wadehra M.
Exploring
the Past, Present, and Future of Anti-Angiogenic Therapy in
Glioblastoma.
Cancers
(Basel). 2023 Jan 29;15(3):830∟.
doi: 10.3390/cancers15030830∟.
PMID: 36765787∟.
Review. ˍ
Choi
JY.
Medulloblastoma:
Current Perspectives and Recent Advances.
Brain
Tumor Res Treat. 2023 Jan 30;11(1):28-38∟.
doi: 10.14791/btrt.2022.0046∟.
PMID: 36762806∟.
Review. ˍ
Gkantinas G,
Tataki EΙ, Lykoudis PM, Lelekaki E, Kouki P.
Clinical
Effects and Adverse Events Associated With Desflurane Use in Adult
Patients Undergoing Supratentorial Craniotomy: A Systematic
Review.
J
Neurosurg Anesthesiol. 2023 Jan 30∟.
doi: 10.1097/ANA.0000000000000905∟.
PMID: 36706431∟.
Review˰ ˍ
Lim DH.
Role
of Radiotherapy in Patients With Relapsed Medulloblastoma.
Brain
Tumor Res Treat. 2023 Jan 30;11(1):22-27∟.
doi: 10.14791/btrt.2022.0033∟.
PMID: 36762805∟.
Review. ˍ
Parsels LA,
Wahl DR, Koschmann C, Morgan MA, Zhang Q.
Developing
H3K27M mutant selective radiosensitization strategies in diffuse
intrinsic pontine glioma.
Neoplasia.
2023 Jan 30;37:100881∟.
doi: 10.1016/j.neo.2023.100881∟.
PMID: 36724689∟.
Review. ˍ
Rahman R,
Janowski M, Killick-Cole CL, Singleton WGB, Campbell E, Walczak P,
Khatua S, Faltings L, Symons M, Schneider JR, Kwan K, Boockvar JA,
Gill SS, Oliveira JM, Beccaria K, Carpentier A, Canney M, Pearl M,
Veal GJ, Meijer L, Walker DA.
Childhood
Brain Tumors: A Review of Strategies to Translate CNS Drug
Delivery to Clinical Trials.
Cancers
(Basel). 2023 Jan 30;15(3):857∟.
doi: 10.3390/cancers15030857∟.
PMID: 36765816∟.
Review. ˍ
Reuss
DE.
Updates
on the WHO diagnosis of IDH-mutant glioma.
J
Neurooncol. 2023 Jan 30∟.
doi: 10.1007/s11060-023-04250-5∟.
PMID: 36717507∟.
Review. ˍ
Rivera D, Schupper AJ, Bouras A, Anastasiadou M, Kleinberg L,
Kraitchman DL, Attaluri A, Ivkov R, Hadjipanayis CG.
Neurosurgical
Applications of Magnetic Hyperthermia Therapy.
Neurosurg
Clin N Am. 2023 Jan 30;34(2):269-283∟.
doi: 10.1016/j.nec.2022.11.004∟.
PMID: 36906333∟.
Review˰
ˍ
Gatto L,
Franceschi E, Tosoni A, Di Nunno V, Bartolini S, Brandes
AA.
Glioblastoma
treatment slowly moves towards change: novel druggable targets and
translational horizons in 2022.
Expert
Opin Drug Discov. 2023 Jan 31∟.
doi: 10.1080/17460441.2023.2174097∟.
PMID: 36718723∟.
Review˰ ˍ
Huang Z,
Dewanjee S, Chakraborty P, Jha NK, Dey A, Gangopadhyay M, Chen XY,
Wang J, Jha SK.
CAR
T cells: engineered immune cells to treat brain cancers and
beyond.
Mol
Cancer. 2023 Jan 31;22(1):22∟.
doi: 10.1186/s12943-022-01712-8∟.
PMID: 36721153∟.
Review. ˍ
Szasz
AM, Arrojo Alvarez EE, Fiorentini G, Herold M, Herold Z, Sarti D,
Dank M.
Meta-Analysis
of Modulated Electro-Hyperthermia and Tumor Treating Fields in the
Treatment of Glioblastomas.
Cancers
(Basel). 2023 Jan 31;15(3):880∟.
doi: 10.3390/cancers15030880∟.
PMID: 36765840∟.
Meta-analysis. ˍ